Table 3.
The characteristics of 140 patients with nonalcoholic fatty liver disease at baseline and after 1 year diet therapy.
| Variable | Baseline | After 1 Year | p-Value |
|---|---|---|---|
| PNPLA3, CC/CG/GG | 30/58/52 | ||
| HSD17B13, AA/AG/GG | 72/57/11 | ||
| BMI, kg/m2 | 27.6 (17.6–45.2) | 26.7 (17.6–46.2) | <0.001 |
| Albumin, g/dL | 4.5 (3.5–5.2) | 4.4 (3.6–5.3) | 0.358 |
| AST, IU/L | 42 (12–162) | 33 (14–121) | <0.001 |
| ALT, IU/L | 54 (14–233) | 40 (8–216) | <0.001 |
| GGT, IU/L | 59.5 (14–533) | 50.5 (9–456) | <0.001 |
| Platelet count, ×103/μL | 222.5 (76–444) | 227 (56–472) | 0.124 |
| Total cholesterol, mg/dL | 201.5 (94–347) | 193 (88–312) | 0.493 |
| TG, mg/dL | 145 (49–739) | 136 (49–714) | 0.117 |
| LDL–C, mg/dL | 119 (33–252) | 120 (33–231) | 0.131 |
| HDL–C, mg/dL | 50 (21–96) | 50.5 (22–116) | 0.330 |
| FPG, mg/dL | 109 (71–236) | 106.5 (61–387) | 0.830 |
| HbA1c, % | 6.0 (5.0–11.2) | 6.0 (4.9–11.8) | 0.534 |
| FIB-4 index | 1.29 (0.28–7.83) | 1.31 (0.27–11.58) | 0.001 |
| CAP, dB/m | 309.5 (159–400) | 298 (129–400) | 0.020 |
| LSM, kPa | 8.8 (2.9–46.4) | 6.5 (2.4–32.4) | <0.001 |